Seminars in Cancer Biology
Seminars in Cancer Biology is a journal indexed in SJR in Cancer Research with an H index of 190. It has a price of 2840 €. It has an SJR impact factor of 4,016 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,016.
Seminars in Cancer Biology focuses its scope in these topics and keywords: role, cancer, nuclear, oncogenesis, lymphomagenesisa, cancerinfectious, researchnotch, mechanismsthe, abnormalities, malignancy, ...
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
4,016
H-index
190
Docs (year)
45
Docs 3y
681
Total refs
7339
Cites 3y
10625
Citable 3y
651
Cites/Doc 2y
15.8
Ref/Doc
163.09
Immediate OA
2840 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis
View moreWhere is the biology of CLL leading us?
View moreEpitope selection and development of peptide based vaccines to treat cancer
View moreEpigenetic and proteolytic inactivation of 14-3-3s in breast and prostate cancers
View moreDesigner self-assembling peptide nanofiber scaffolds for 3D tissue cell cultures
View moreDefinition of tumor antigens suitable for vaccine construction
View moreCyclin E as a prognostic and predictive marker in breast cancer
View moreCurrent criteria to establish human carcinogens
View moreConnecting mitotic instability and chromosome aberrations in cancer - can telomeres bridge the gap?
View moreConditional animal models: a strategy to define when oncogenes will be effective targets to treat cancer
View moreCommentary
View moreChromosomal translocation t(14;18) in healthy individuals
View moreChemokines in neuroectodermal tumour progression and metastasis
View more14-3-3 proteins and cancer biology
View moreCancer stem cells: Differentiation block or developmental back-tracking?
View moreBurkitt lymphoma
View moreBreast cancer stem cells: Features, key drivers and treatment options
View moreAutocrine signaling in carcinoma: VEGF and the a6beta4 integrin
View moreAugmenting the immunogenicity of carbohydrate tumor antigens
View moreAssessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests
View moreApoptosis and cancer: where we are and where to go ...
View moreAlpha2beta1 integrin in cancer development and chemoresistance
View moreAGEs, RAGEs and s-RAGE; friend or foe for cancer
View moreAdvances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
View more